Friday, June 24, 2022

Medical Marijuana Inc (OTCMKTS:MJNA) Goes on a Roadshow

Medical Marijuana Inc (OTCMKTS:MJNA) is yet another name in the cannabis patch that we have highlighted of late as well-positioned for gains into the November 8 referendum on pot in America. We think it’s a good idea to frame the concept this way as the upcoming votes will likely play a major role in the overall inertia of a potential national level shift in legislation.

However, for MJNA, many of its products are already available in all 50 states. That said, the referendum concept is still important here for what matters as a brand identity. Make no mistake: this is the first publicly traded stock in the cannabis patch in the US marketplace, and a continued acceptance of marijuana, cannabis, CBD, and hemp, overcoming the negative stigma so long attached to the group, is a monstrously important catalyst for shares of MJNA stock. For example, note that shares of MJNA stock are held by precisely zero institutional investment managers. We suspect that further legitimation of the related space could change this over time.

Medical Marijuana Inc (OTCMKTS:MJNA) trumpets itself as an investment holding company that operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high-value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries.

The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry.

It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products.

In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry.

Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products.

Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. The company was incorporated in 2003 and is headquartered in Poway, California.

Find out when MJNA stock reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

Recent action has seen 50% tacked on to share pricing for the company in the past month. Market participants may want to pay attention as MJNA stock has evidenced sudden upward volatility on many prior occasions.

In addition, the company is adding to its current list of catalysts through a roadshow of sorts.

MJNA’s subsidiary HempMeds exhibited at the Oct. 4-8 SupplySide West Conference in Las Vegas. SupplySide West is a one-stop resource to accelerate manufacturers’ ability to find ingredients to aid in successful launches of finished products. “SupplySide West provides us with a great opportunity to educate some of the more than 14,000 global buyers and manufacturers that attend the Expo about our CBD hemp oil products, which have become highly sought after by consumers across the globe, and the plethora of benefits they can provide to patients around the world,” said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus.

HempMeds is also set to exhibit at the Oct. 14-15 New West Summit in San Francisco. Meanwhile, parent advocates Katiele and Norberto Fischer are visiting the U.S. for the first time to speak on an Oct. 14 panel at the Summit to share their story of how their fight to save daughter Anny helped legalize medical cannabis in Brazil.

This process demonstrates the crucial importance of public awareness to the success of MJNA stock.

The New West Summit, being held on October 14-15 at the Embarcadero Center in San Francisco, is the first conference to focus exclusively on the game-changing, disruptive developments in technology, investment and media within the cannabis space, which for legal cannabis is projected to have a $10 billion annual economic impact.

The Fischers will be speaking on the “CBD: Getting Real” panel at the Summit from 3:30 p.m. to 4:30 p.m. on Oct. 14 that will feature statistics and case studies from parents, athletes, veterans, executives and doctors on the therapeutic benefits of cannabidiol and provide an overview of the endo-cannabinoid system.

“We applaud the Fischers’ courage to continue sharing their daughter Anny’s story, and as we’ve seen time and time again in legalization efforts across the nation, families of young children with special needs are helping drive the conversation around cannabis reform,” said Medical Marijuana, Inc. Chief Executive Officer, Dr. Stuart Titus. “The inspiring stories of brave parents like the Fischers, and children like their daughter Anny, are why the hard-working people at our Company work long hours and make significant personal sacrifices to further the cause. We’re so thankful that the Fischers have this opportunity to share their personal story at the Summit and further educate attendees on the benefits of medical cannabis, including non-psychoactive CBD. It’s families like the Fischers that will help reshape the world’s perceptions and offer assistance to others who are suffering across the globe.”

Now commanding a market cap of $183.7M, MJNA has a decent store ($266.17k) of cash on the books, alongside total assets above $210M, which is balanced by an appreciable load ($13.67M) of total accumulated debt. The company’s trailing twelve month top line stands at $9.2 mln. That is down on a quarterly basis. But much hangs in the balance just weeks from now. For continuing coverage on $MJNA and our other hot stock picks, sign up for our free newsletter today and get our next hot stock pick!

Related Articles


Please enter your comment!
Please enter your name here

Stay Connected


Latest Articles